The following is a summary of "Transcatheter Aortic Valve Replacement Beyond Severe Aortic Stenosis: JACC State-of-the-Art ...
Early surgical or transcatheter aortic valve replacement is not typically recommended for severe aortic stenosis in the ...
Medical Device Network on MSN7d
Medtronic announces two-year trial outcomes of Evolut TAVRMedtronic has announced the SMART trial’s two-year outcomes of Evolut TAVR for aortic stenosis (AS) and small aortic annulus.
Veronica Even expected to bring her newborn, Theodore, home for Christmas. Instead, she watched as he was rushed to Manning ...
The implantation of the new valve is done without the need to open the heart completely, thereby drastically reducing the ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, the largest international ...
Testimonials from initial use of the TREO FIT physician-modified endovascular graft highlight the system’s potential for ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today released the two-year results of the SMa ...
Procedural planning and attention to detail can help, but heart teams should be realistic about what lies ahead, experts say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback